glp 1 and ibd 🚨 GLP-1 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 Small peptide encoded by MALAT1

Qu for assay and technical support

The University of Hong Kong

Many denials are reversed once the insurer receives documentation showing the medication is necessary

GLP-1 medicines, initially developed for blood glucose and weight control, improve outcomes in people with cardiovascular, kidney, liver, arthritis, and sleep apnea disorders, actions mediated in part through anti-inflammatory and metabolic pathways, with some benefits partly independent of the degree of weight loss achieved

Robert was sent to Scotland at the age of eight to take charge of his father's apothecary and initially had a peripatetic education before he landed up studying medicine at the University of Edinburgh

Next-generation hyaluronic acid complex delivers deep, lasting hydration for a fresh, dewy glow